Denali Therapeutics Stock Price on January 4, 2019
| DNLI Stock | USD 15.56 0.55 3.41% |
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 15.56, as last reported on the 25th of April, with the highest price reaching 16.80 and the lowest price hitting 15.56 during the day.
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. We consider Denali Therapeutics not too volatile. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0054, which denotes the company had a 0.0054% return per unit of risk over the last 3 months. We have found thirty technical indicators for Denali Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Denali Therapeutics' Mean Deviation of 3.19, coefficient of variation of 9305.82, and Downside Deviation of 4.28 to check if the risk estimate we provide is consistent with the expected return of 0.0331%.
As of now, Denali Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Denali Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 0.63, while Total Stockholder Equity is projected to decrease to under 712.9 M. . The Denali Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.36, while Price To Sales Ratio is projected to decrease to 8.47. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of December 2017 | 200 Day MA 20.9147 | 50 Day MA 19.1086 | Beta 1.331 |
Denali |
Sharpe Ratio = 0.0054
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNLI |
Estimated Market Risk
| 6.13 actual daily | 54 54% of assets are less volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Denali Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding Denali Therapeutics to a well-diversified portfolio.
Price Book 2.4648 | Enterprise Value Ebitda (8.66) | Price Sales 7.6878 | Shares Float 120.2 M | Wall Street Target Price 41.19 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Denali Therapeutics Stock history
Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.4 M | 86.7 M | |
| Net Loss | -293.4 M | -278.7 M |
Denali Therapeutics Quarterly Net Working Capital |
|
Denali Therapeutics Stock Technical Analysis
Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Denali Therapeutics Period Price Range
Denali Therapeutics April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns
Denali Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0156 | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0157 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Denali Stock analysis
When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Denali Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.06) | Revenue Per Share 2.406 | Quarterly Revenue Growth (1.00) | Return On Assets (0.09) | Return On Equity (0.14) |
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.